MoBiTec GmbH, Germany, Closes Distribution Agreement for Transcreener® HTS System Platform with BellBrooks Labs, USA

BellBrook Labs, USA, is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. Their proprietary Transcreener® HTS Platform was developed to move more new targets into HTS more rapidly, and to streamline selectivity profiling within a target family. The partnership with MoBiTec, Germany, will enable BBL to offer their excellent products for High-Throughput Screening to scientists in Germany. - March 14, 2012 - MoBiTec GmbH

Research Article by Stevens Professor Stamnes Achieves Most Citations in the History of the Journal of Applied Optics

Dr. Knut Stamnes' seminal paper has informed research in climate change and the "Greenhouse" effect. His work is the most cited in the 50-year history of the influential journal Applied Optics, according to their recently released anniversary list. - March 08, 2012 - Stevens Institute of Technology

Bioo Scientific’s Newest ELISA Facilitates the Screening of Meat Samples for Colistin Contamination

Bioo Scientific recently launched the MaxSignal® Colistin ELISA Test Kit for reliable, rapid and cost effective screening of colistin contamination in poultry, beef and pork samples. - March 07, 2012 - Bioo Scientific

Dr. David Cappelleri Receives NSF CAREER Award for Ground-Breaking Work in Microrobotics

Microrobots can help detect cancer cells and drive advancement toward microsurgical applications. - March 02, 2012 - Stevens Institute of Technology

MoBiTec GmbH, Germany, to Exhibit at Annual Conference of the Association for General and Applied Microbiology (VAAM) 2012 in Tuebingen, Germany

Presentation of new High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy, Systems for Safe Collection and Transportation of Parasite Material, and a Comprehensive Compilation Booklet on Cell Viability and Cytotoxicity Assays at German Conference of the Association for General and Applied Microbiology (VAAM) 2012. - March 02, 2012 - MoBiTec GmbH

MoBiTec GmbH, Germany, Offers a New Photoconvertible and Photoactivatible Fluorescent Protein Suitable for High-Resolution Microscopy: mIrisFP

MoBiTec GmbH, Germany, supplier of fluorescent probes, screening kits and imaging ware for cutting-edge fluorescence applications and microscopy, introduces mIrisFP, a photoconvertible and photoactivatible fluorescent protein suitable for High-Resolution microscopy: mIrisFP - February 29, 2012 - MoBiTec GmbH

Mitegen Announces Continued Expansion of Product Lines and Offerings for Crystallographers

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, recently announced numerous expansions to both their patented product portfolio and to their line of distributed products. - February 25, 2012 - MiTeGen, LLC

MoBiTec GmbH, Germany, Launches Sale of High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy

MoBiTec GmbH, Germany, Launches Sale of High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy

MoBiTec GmbH, Germany, supplier of fluorescent probes and research chemicals, introduces a collection of high end imaging tools for cell based imaging, assays and arrays. The product line includes Imaging Dishes and adequate Stage Frames, Imaging Plates, Imaging Chambers, Slide Tray Plates and Affinity Adhesion Slides. For the design of the products excellent materials, high quality processing and assembly technologies and innovative construction principles were chosen. - February 24, 2012 - MoBiTec GmbH

Mitegen Announces Distribution Agreement with Mexico Diffractia S. de R.L.de C.V.

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Mexico Diffractia S. de R.L.de C.V. of... - February 24, 2012 - MiTeGen, LLC

New Propulsion Method for Low-Cost Microsatellites

Stevens doctoral candidate Kyle Godin has received the Abe M. Zarem Award for research on a low-cost thruster that promises to allow universities and independent researchers to launch craft, potentially democratizing space exploration. - February 19, 2012 - Stevens Institute of Technology

Bioo Scientific’s New ELISAs Increase Speed and Sensitivity of Aflatoxin M1 Analysis in Milk

Bioo Scientific launched two new MaxSignal® Aflatoxin M1 ELISA Kits; one with increased speed and other with increased sensitivity. - February 13, 2012 - Bioo Scientific

Stevens Professor Ting Yu Receives AFOSR Grant to Study Entanglement in Quantum Systems

Stevens Professor Ting Yu has received an AFOSR grant to study entanglement in quantum systems, potentially bringing quantum technology closer to reality. - February 10, 2012 - Stevens Institute of Technology

Dr. Thomas Wakeman Appointed Chair of Marine Group at Transportation Research Board

Dr. Thomas Wakeman of Stevens Institute of Technology has been appointed chair of the Transportation Research Board (TRB), a division of the National Research Council, which serves as an independent adviser to the President, the Congress and federal agencies on scientific and technical questions of national importance. - February 10, 2012 - Stevens Institute of Technology

Stevens Professor Darinka Dentcheva Appointed to SIAM Review Editorial Board

Dr. Dentcheva, an expert on stochastic optimization for efficient energy production as well as risk-averse models for economic systems and medical treatment, has been appointed to the editorial board of the SIAM Review, the most influential journal in the field of applied mathematics. - February 09, 2012 - Stevens Institute of Technology

SFL’s Managing Director to Speak at Healthcare Businesswomen’s Association Event

SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be speaking at the upcoming Healthcare Businesswomen’s Association European meeting entitled “The Role of Regulatory Affairs in Successful Development and Launch of Healthcare Products” to be held in Basel, Switzerland. - February 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd

MaxSignal® Malachite Green/LMG ELISA is Included in the USDA’s Chemistry Laboratory Guidebook

The USDA added the MaxSignal® Malachite Green ELISA to the Chemistry Laboratory Guidebook as the recommended method for screening fish for Malachite Green contamination. - February 06, 2012 - Bioo Scientific

Bio3 Research S.r.l. Completed Its Acquisition of the Full Ownership of All the Patents in Its Portfolio Concerning HMGB1

Bio3 Research S.r.l. (Milan/Italy) is pleased to announce that it has completed its acquisition of the full ownership of all the patents in its portfolio concerning HMGB1 (High Mobility Group Box 1). HMGB1 patents have been granted to Bio3 Research in the USA, Europe, Japan, Australia, Mexico,... - February 02, 2012 - Bio3 Research S.r.l.

BioResource International Supports the Inter-Faith Food Shuttle

BioResource International, Inc. (www.briworldwide.com) is proud to announce their continuing support of the Inter-Faith Food Shuttle (www.foodshutttle.org), through their sponsorship of the 18th Annual Taste of Hope Gala (http://tasteandblossoms.org/). The gala, benefiting the Inter-Faith Food... - January 29, 2012 - BioResource International, Inc

BioResource International, Inc. Presents Latest Research at the International Poultry Expo

Scientists from the Agricultural biotechnology company BioResource International, Inc. (www.briworldwide.com) presented their latest research at the International Poultry Science Forum held in conjunction with the International Poultry Expo in Atlanta from January 23-26, 2012... - January 29, 2012 - BioResource International, Inc

Novus Biologicals Added as New Preferred Vendor for the University of Washington

Novus Biologicals is excited to be a preferred vendor for the University of Washington. Novus’ extensive product line will soon be added to the UW online ordering system, and all UW researchers will now receive 5% off any order. Novus Biologicals is committed to developing and maintaining... - January 28, 2012 - Novus Biologicals

Arthritis and Bacterial Infection Research Nabs Win for Stevens Student

Stevens undergrad demonstrates how bacteria infection plays a role in arthritis. - January 19, 2012 - Stevens Institute of Technology

CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul and the Ministry of Knowledge Economy

CrystalGenomics, Inc. (KOSDAQ: CRYSTAL [083790]), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund (KSLSF). This is the third time within... - January 16, 2012 - CrystalGenomics, Inc.

John Quackenbush to Speak at CHI’s Bioinformatics & Cancerinformatics Conference, February 21-23, San Francisco, CA

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session. - January 12, 2012 - Cambridge Healthtech Institute

CrystalGenomics to Present at J.P. Morgan Healthcare Conference on January 12

CrystalGenomics, Inc. (KOSDAQ: CRYSTAL (083790)), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that Joong Myung Cho, Ph.D., President & CEO, will present an overview of CrystalGenomics’ business strategy and an update on its development pipeline on... - January 11, 2012 - CrystalGenomics, Inc.

NEXTflex™ Modules Lower the Cost of Next Generation Sequencing Sample Prep

Bioo Scientific recently launched the NEXTflex™ DNA, ChIP-Seq, and PCR-Free Modules, which were designed to lower the cost of library prep for high throughput users. Modules are available for each step in the library preparation protocol including end repair, adenylation, ligation and PCR. - January 06, 2012 - Bioo Scientific

Bioo Scientific Simplifies the Analysis of Apoptotic Bodies with the D-Pop™ Kit

Bioo Scientific launched the D-Pop™ Kit to capture apoptotic bodies from cell-free fluids and to extract DNA from them offering a non-invasive source of biomarkers for the diagnosis and prognosis of diseases. - January 05, 2012 - Bioo Scientific

Declan Doogan of Amarin to Keynote CHI’s Conference on Phase III Clinical Trials

Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum. - December 26, 2011 - Cambridge Healthtech Institute

New Lightning-Link® Rapid Antibody Labeling Kits Now for DyLight™ Dyes

The Lightning-Link® Rapid Antibody kits allow direct antibody labeling reactions to be set up in seconds and used within just 20 minutes. Novus has recently expanded their Lighting-Link® Rapid kits to include the following DyLight™ dyes. Lightning-Link® Rapid DyLight... - December 17, 2011 - Novus Biologicals

Novus New Lab Program - Receive 20% Off for New Labs

Novus Biologicals understands the funding constraints and logistical difficulties of starting a new lab. Therefore, Novus is proud to announce a New Lab Program, offering 20% off Novus purchases for your first 3 months. Additionally, Novus will provide a welcome kit full of useful tools for your... - December 16, 2011 - Novus Biologicals

Novus Products Now Available Through the UPENN Cell Center Stockroom

Novus is proud to announce that select products will now be available through the University of Pennsylvania’s Cell Center Stockroom. Researchers who order through the Cell Center Stockroom will receive a 20% discount off the regular list price and free shipping. The Cell Center Stockroom... - December 15, 2011 - Novus Biologicals

Fitzsimons Redevelopment Authority Announces Second Phase of Strategic Refocus with $8 Million Expansion to Bioscience Park Center with 37,000-Square-Foot Accelerator

The Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience Park Center (BPC) by roughly 50% with an $8 million, 37,000-square-foot accelerator structure. The new accelerator space will be leased to existing tenants graduating from the incubator and other companies in the modest growth stage. - December 12, 2011 - Fitzsimons Redevelopment Authority

SFL’s Public Affairs Now Covers Bioethics

SFL’s Public Affairs team, helping organizations shape EU rules, saw exciting expansion in 2011. - December 11, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd

Stevens Researcher Makes Inkjet-Printed Electronics Using Graphene

Dr. Woo Lee of Stevens and Partners in the US Army Win Academic R&D Award from Printed Electronics Conference and Tradeshow. - December 09, 2011 - Stevens Institute of Technology

SFL Thanks Clients and Partners for Successful Collaborations

With the end of 2011 approaching, SFL can reflect on a very successful year of extension and expansion in all areas. The company’s client base has expanded internationally as demand has grown for its personalized and comprehensive services in the fields of Regulatory Affairs, Public Affairs, Legal Services and Medical Communication. - December 08, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd

UNICEF and Stevens Professor Improve Drinking Water in Bangladesh

Dr. Xiaoguang Meng introduced pioneering technologies for effective, affordable, and easy to use water purification during a recent expedition to Bangladesh, where an environmental crisis affects the drinking water of tens of millions of people. - December 08, 2011 - Stevens Institute of Technology

DARPA Grant Streamlines Data for the Department of Defense

Researchers at Stevens Institute of Technology unify DoD data streams through competitive new DARPA grant. - December 07, 2011 - Stevens Institute of Technology

PharmaJet Receives Grand Challenges Explorations Funding

PharmaJet Inc. announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to pursue innovations that address persistent health and development challenges. Dr. Linda... - November 16, 2011 - PharmaJet, Inc.

Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus with Appointment of Four Key Leaders in the Bioscience Industry to Its Board of Directors

The Fitzsimons Redevelopment Authority (FRA) is adding four of the area's most well-known and successful leaders in the Bioscience Industry to its Board of Directors. Change in board composition is the result of a strategic refocus for the FRA, and those recently appointed to the board include: Donald M. Elliman, Jr.; William Freytag, PhD; James C. T. Linfield; and David Perez. - November 15, 2011 - Fitzsimons Redevelopment Authority

Mitegen Announces Distribution Agreement with Helix Biotech in Malaysia

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Helix Biotech (M) SDN BHD of... - November 12, 2011 - MiTeGen, LLC

Mitegen Announces Mutual Distribution Agreements with AJK Analytical Services

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with AJK Analytical Services. - November 12, 2011 - MiTeGen, LLC

Better Surfing Through Science at Stevens Institute of Technology

Stevens Institute of Technology doctoral candidate designs artificial reefs for coastal protection and teaches high school kids about engineering. - November 11, 2011 - Stevens Institute of Technology

Novus Biologicals Announces New ROBLD3 Antibody Made Using SDIX Genomic Antibody Technology™

Novus Biologicals announced today a new ROBLD3 antibody (catalog number NBP1-71687) for use in research on cell growth regulation. This ROBLD3 antibody was made using SDIX Genomic Antibody TechnologyTM. ROBLD3 is one of three individual proteins (ROBLD3, c11orf59 & MAPKSP1) that form the... - November 11, 2011 - Novus Biologicals

Announcing the Release of a Novel Tool for the Assessment of Porcine Islet Functionality: the Mercodia Porcine C-peptide ELISA

Announcing the Release of a Novel Tool for the Assessment of Porcine Islet Functionality: the Mercodia Porcine C-peptide ELISA

Mercodia announced the release of their new Porcine C-Peptide ELISA at the recent Cell Transplant Society (CTS) and International Xenotransplantation Association (IXA) meeting in Miami, Florida, October 23-26. This assay provides the type 1 diabetes, and more specifically the islet transplantation,... - November 10, 2011 - Mercodia Inc.

Dr. Alexander Sutin of Stevens Elected Acoustical Society of America Fellow

Dr. Sutin develops acoustical underwater monitoring for port and harbor security. - November 10, 2011 - Stevens Institute of Technology

Rapid Spectrum Sensing for Cognitive Radio

Dr. Hongbin Li of Stevens Institute of Technology Wins Outstanding Paper Award at IEEE Africon 2011. - November 05, 2011 - Stevens Institute of Technology

Bioo Scientific Launched the NEXTflex™ ChIP-Seq Kit for Improved Genome Wide Analysis of DNA-Protein Interactions

Bioo Scientific announced the launch of the NEXTflex™ ChIP-Seq Kit which was designed to simplify the genome-wide profiling of DNA-protein interactions by improving the traditional ChIP-Seq protocol and offering flexible barcoding options to facilitate multiplexing. ChIP-seq analysis is... - November 04, 2011 - Bioo Scientific

San Francisco Clinical Affairs Consulting Firm Rebrands as The Jon Block Group: Expanded Team, Enhanced Capabilities

Jon E. Block, Ph.D., Inc., an internationally recognized clinical affairs consulting firm based in San Francisco announced today it has rebranded as The Jon Block Group (www.JonBlockGroup.com). The Jon Block Group serves many of the world’s top medical device firms, providing senior-level... - November 02, 2011 - Jon Block Group

Mitegen Announces Mutual Distribution Agreements with XTalQuest Inc., Ltd.

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with XTalQuest Inc., Ltd a Beijing based provider of high quality crystallization plates, screening solutions, and other products for crystallography. - November 01, 2011 - MiTeGen, LLC

Stevens Professor David J. Cappelleri Selected for National Academy of Engineering Symposium

One of 65 young engineering educators selected to participate in curriculum development workshop. - October 30, 2011 - Stevens Institute of Technology

Novus Biologicals Announces New CHD7 Antibody Made Using SDIX Genomic Antibody Technology™

Novus Biologicals announced today a new CHD7 antibody (catalog number NBP1-77393) for use in research on transcription regulation and CHARGE syndrome. This CHD7 antibody was made using SDIX Genomic Antibody TechnologyTM. CHD7 is an ATP-dependent chromatin remodeler that interacts closely with SOX2... - October 29, 2011 - Novus Biologicals

Press Releases 701 - 750 of 1,228